Gabrielle Morris

This inventor holds 5 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Ultragenyx Pharmaceutical Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabrielle Morris. Retrieved from https://idiyas.com/inventor/gabrielle-morris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

5 out of 34

Ultragenyx Pharmaceutical Inc.

patents

Years Active: 2016-2026

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12551461 - Compositions of triglycerides and uses thereof (2026-02-17),

2. 9937243 - Sialylated glycoprotein compositions and uses thereof (2018-04-10),

3. 9687532 - Sialylated glycoprotein compositons and uses thereof (2017-06-27),

4. 9457068 - Sialylated glycoprotein compositions and uses thereof (2016-10-04),

5. 9457067 - Sialylated glycoprotein compositions and uses thereof (2016-10-04),

Title: Innovations by Gabrielle Morris

Introduction

Gabrielle Morris is an accomplished inventor based in Novato, California. She has made significant contributions to the field of biotechnology, particularly in the development of sialylated glycoprotein compositions. With a total of four patents to her name, Morris is recognized for her innovative approaches to treating various medical conditions.

Latest Patents

Morris's latest patents include two notable applications related to sialylated glycoprotein compositions. The first patent focuses on the compositions and methods of their use in treating various conditions and disorders. The second patent reiterates the same theme, emphasizing the potential therapeutic applications of these glycoprotein compositions.

Career Highlights

Gabrielle Morris is currently employed at Ultragenyx Pharmaceutical Inc., where she continues to advance her research and development efforts. Her work at this leading biotechnology company has positioned her as a key player in the industry, contributing to innovative solutions for unmet medical needs.

Collaborations

Morris collaborates with talented professionals in her field, including Steven Jungles and Jeff Grubb. These partnerships enhance her research capabilities and foster a collaborative environment for innovation.

Conclusion

Gabrielle Morris exemplifies the spirit of innovation in biotechnology through her patents and work at Ultragenyx Pharmaceutical Inc. Her contributions to the field are paving the way for new treatments and advancements in medical science.

Profile summary based on public USPTO records.